首页 > 最新文献

Kaku igaku. The Japanese journal of nuclear medicine最新文献

英文 中文
[2017/2018 Working Group Report. Multicenter study of 123 I-IMP cerebral blood flow SPECT normal database for statistical analysis constructed using CT attenuation correction : Survey study on needs and problems from the side of verification by dementia disease]. [2017/2018工作小组报告]用CT衰减校正构建用于统计分析的123 I-IMP脑血流SPECT正常数据库的多中心研究:从痴呆病验证的角度对需求和问题的调查研究[j]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.wgr.2033
{"title":"[2017/2018 Working Group Report. Multicenter study of 123 I-IMP cerebral blood flow SPECT normal database for statistical analysis constructed using CT attenuation correction : Survey study on needs and problems from the side of verification by dementia disease].","authors":"","doi":"10.18893/kakuigaku.wgr.2033","DOIUrl":"https://doi.org/10.18893/kakuigaku.wgr.2033","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10507057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Encouragement Award Summary 1]. 【奖励总结1】。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.57.A3
{"title":"[Encouragement Award Summary 1].","authors":"","doi":"10.18893/kakuigaku.57.A3","DOIUrl":"https://doi.org/10.18893/kakuigaku.57.A3","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38552854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)]. 放射性药品不良反应调查第41次报告(2018年第44次调查)。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.rp.2071
Hiroshi Matsuda, Tomoya Uehara, Hidehiko Okazawa, Sunao Mizumura, Kunihiko Yokoyama, Mana Yoshimura

This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2018 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 999 institutions among 1,230 to which the questionnaire had been sent. Fourteen cases of adverse reactions were reported. A total of 1,017,702 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.4. No case of deficient products was reported.

本调查是为了调查日本2018财年放射性药物不良反应的发生率。该报告是根据对核医学机构的问卷调查得出的。在接获问卷的1,230所院校中,共有999所院校作出答复。报告不良反应14例。共报告了1,017,702例放射性药物管理。不良反应发生率为1.4 / 10万例。未发现缺陷产品。
{"title":"[The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)].","authors":"Hiroshi Matsuda,&nbsp;Tomoya Uehara,&nbsp;Hidehiko Okazawa,&nbsp;Sunao Mizumura,&nbsp;Kunihiko Yokoyama,&nbsp;Mana Yoshimura","doi":"10.18893/kakuigaku.rp.2071","DOIUrl":"https://doi.org/10.18893/kakuigaku.rp.2071","url":null,"abstract":"<p><p>This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2018 in Japan. It was based on the responses to questionnaires sent to nuclear medicine institutions. Replies were obtained from 999 institutions among 1,230 to which the questionnaire had been sent. Fourteen cases of adverse reactions were reported. A total of 1,017,702 radiopharmaceutical administrations were reported. The incidence of adverse reactions per 100,000 cases was 1.4. No case of deficient products was reported.</p>","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37658077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[2017/2018 Working Group Report. Establishment of standard PET / MRI imaging method and quantitative evaluation]. [2017/2018工作小组报告]标准PET / MRI成像方法的建立及定量评价]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.wgr.2034
{"title":"[2017/2018 Working Group Report. Establishment of standard PET / MRI imaging method and quantitative evaluation].","authors":"","doi":"10.18893/kakuigaku.wgr.2034","DOIUrl":"https://doi.org/10.18893/kakuigaku.wgr.2034","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37793635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The 92nd Japan Nuclear Medicine Society Kanto Koshinetsu Regional Association]. [第92届日本核医学学会关东小越地区协会]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.arm.2035
{"title":"[The 92nd Japan Nuclear Medicine Society Kanto Koshinetsu Regional Association].","authors":"","doi":"10.18893/kakuigaku.arm.2035","DOIUrl":"https://doi.org/10.18893/kakuigaku.arm.2035","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37803923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis]. [全国日常生活活动受限患者及血液透析患者回避放射性核素靶向治疗情况调查]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.oa.1902
Hiroshi Mori, Anri Inaki, Daiki Kayano, Hiroshi Wakabayashi, Makoto Hosono, Tatsuya Higashi, Noboru Oriuchi, Koichiro Abe, Mayuki Uchiyama, Seigo Kinuya

Targeted radionuclide therapy with high-dose radioisotopes should be performed in isolation rooms. Patients can be released only after radioactivity remaining in their bodies becomes less than the limits determined by the release criteria in order to secure public protection. Patients are asked to stay in isolation rooms for a few days. Physicians often face difficulties to carry out therapy in patients with limited activities of daily living and those undergoing hemodialysis, and have to avoid therapy in such cases. The Japanese Society of Nuclear Medicine conducted a nationwide survey in order to find out the actual situation. The survey results should reflect future improvement of therapeutic environment in collaborating with related societies and administrative bodies.

高剂量放射性同位素的靶向放射性核素治疗应在隔离室进行。只有在病人体内残留的放射性物质低于释放标准规定的限度后,才能释放,以确保公众的保护。病人被要求在隔离室呆几天。对于日常生活活动受限的患者和血液透析患者,医生往往难以实施治疗,不得不避免治疗。日本核医学学会为了了解实际情况,在全国范围内进行了调查。调查结果应与相关协会和行政机构合作,反映未来治疗环境的改善。
{"title":"[The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis].","authors":"Hiroshi Mori,&nbsp;Anri Inaki,&nbsp;Daiki Kayano,&nbsp;Hiroshi Wakabayashi,&nbsp;Makoto Hosono,&nbsp;Tatsuya Higashi,&nbsp;Noboru Oriuchi,&nbsp;Koichiro Abe,&nbsp;Mayuki Uchiyama,&nbsp;Seigo Kinuya","doi":"10.18893/kakuigaku.oa.1902","DOIUrl":"https://doi.org/10.18893/kakuigaku.oa.1902","url":null,"abstract":"<p><p>Targeted radionuclide therapy with high-dose radioisotopes should be performed in isolation rooms. Patients can be released only after radioactivity remaining in their bodies becomes less than the limits determined by the release criteria in order to secure public protection. Patients are asked to stay in isolation rooms for a few days. Physicians often face difficulties to carry out therapy in patients with limited activities of daily living and those undergoing hemodialysis, and have to avoid therapy in such cases. The Japanese Society of Nuclear Medicine conducted a nationwide survey in order to find out the actual situation. The survey results should reflect future improvement of therapeutic environment in collaborating with related societies and administrative bodies.</p>","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38009540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Encouragement Award Summary 2]. [奖励总结2]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.57.A5
{"title":"[Encouragement Award Summary 2].","authors":"","doi":"10.18893/kakuigaku.57.A5","DOIUrl":"https://doi.org/10.18893/kakuigaku.57.A5","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38552855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Special Program]. (特殊项目)。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.57.S31
{"title":"[Special Program].","authors":"","doi":"10.18893/kakuigaku.57.S31","DOIUrl":"https://doi.org/10.18893/kakuigaku.57.S31","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38552860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Special Program Abstracts]. [专题节目摘要]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.57.S61
{"title":"[Special Program Abstracts].","authors":"","doi":"10.18893/kakuigaku.57.S61","DOIUrl":"https://doi.org/10.18893/kakuigaku.57.S61","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38552861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The 83rd Japan Nuclear Medicine Society Northern Japan Regional Association]. [第83届日本核医学学会日本北部地区协会]。
Pub Date : 2020-01-01 DOI: 10.18893/kakuigaku.arm.2031
{"title":"[The 83rd Japan Nuclear Medicine Society Northern Japan Regional Association].","authors":"","doi":"10.18893/kakuigaku.arm.2031","DOIUrl":"https://doi.org/10.18893/kakuigaku.arm.2031","url":null,"abstract":"","PeriodicalId":17738,"journal":{"name":"Kaku igaku. The Japanese journal of nuclear medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37602286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kaku igaku. The Japanese journal of nuclear medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1